Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study

Fig. 6

Decision curve analysis (DCA) for baseline mutations in tumor and ctDNA (A) and longitudinal measurements (B) in predicting 6-month overall survival (OS; left) and progression-free survival (PFS; right). The horizontal axis of the DCA curve is the threshold probability. The vertical axis is the net benefit after the benefit is subtracted from the harm

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us